Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Deva Holding ASIST:DEVA +9.99%66 Gross Margin % is 52.99% as of Jun. 2026, which is 25% above its 10-year median of 42.51. GuruFocus rates IST:DEVA with a GF Score™ of 66/100 and a GF Value™ of ₺82.98 (Fairly Valued). The stock has 8 warning signs investors should review. Among 939 Drug Manufacturers companies, Deva Holding AS ranks worse than 77% on this metric.
Deva Holding AS (IST:DEVA) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Deva Holding AS had a gross margin of 52.99% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Deva Holding AS Gross Margin % Related Terms
Deva Holding AS Gross Margin % Historical Data
* Premium members only.
The historical data trend for Deva Holding AS's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IST:DEVA vs ZTS, UTHR, VTRS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Deva Holding AS's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Deva Holding AS Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Deva Holding AS's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Deva Holding AS's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Deva Holding AS (IST:DEVA) has a Gross Margin % of 52.99% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Deva Holding AS and its competitors. This is 25% above median its historical median of 42.51. Over the past decade, Deva Holding AS's Gross Margin % has ranged from 32.43 to 58.32. According to the industry distribution chart, Deva Holding AS ranks #723 out of 939 companies in the Drug Manufacturers industry, placing it in the top 77%.
Is Deva Holding AS's Gross Margin % too high?
Deva Holding AS's current Gross Margin % of 52.99% is 25% above median its 10-year median of 42.51. Over the past 10 years, this metric has ranged from a low of 32.43 to a high of 58.32. The Drug Manufacturers industry median Gross Margin % is 48.28. Deva Holding AS's value of 52.99% is 9.8% above this industry median. Based on the distribution chart, Deva Holding AS ranks #723 out of 939 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Deva Holding AS has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Deva Holding AS's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Deva Holding AS ranks #723 out of 939 companies for Gross Margin %. This places Deva Holding AS in the lower half of its industry. The industry median Gross Margin % is 48.28. Deva Holding AS's value of 52.99% is 9.8% above this benchmark. Historically, Deva Holding AS's own Gross Margin % has ranged from 32.43 to 58.32 over the past decade. While the company's 10-year median is 42.51 vs. the industry median of 48.28, Deva Holding AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.28, based on 939 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Deva Holding AS's current Gross Margin % of 52.99% is 9.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Deva Holding AS and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Deva Holding AS's current Gross Margin % is 52.99%, which is 25% above median its own 10-year median of 42.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deva Holding AS stock overvalued right now?
Based on GuruFocus' analysis, Deva Holding AS (IST:DEVA) is currently considered Fairly Valued. The stock's GF Value™ is ₺82.98, compared to a current price of ₺79.80 — trading 3.8% below its estimated fair value. The current Gross Margin % is 52.99%, which is 25% above median its 10-year median of 42.51 and 9.8% above the Drug Manufacturers industry median of 48.28. Deva Holding AS's overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Deva Holding AS (IST:DEVA), the current Gross Margin % is 52.99% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Deva Holding AS (IST:DEVA) Overvalued in 2026?
Based on GuruFocus' analysis, Deva Holding AS stock appears to be undervalued.
The current stock price of ₺79.80 is trading 3.8% below its estimated GF Value™ of ₺82.98.
GuruFocus considers Deva Holding AS to be Fairly Valued.
Key valuation signals for IST:DEVA:
Gross Margin %: 52.99% (25% above median its 10-year median of 42.51)
GF Value™: ₺82.98 vs. price of ₺79.80 (3.8% below fair value)
Industry Position: 9.8% above the Drug Manufacturers median (#723 of 939)
No single metric tells the full story. See the IST:DEVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Deva Holding AS is a Turkey-based generic medicine manufacturer. It is engaged in manufacturing and marketing of medicinal products for human use and raw materials. The company also carries out the manufacturing of veterinary drugs, eau de cologne, and medical ampoules. It produces medicines for antineoplastic agents, cardiovascular system, dermatological products, nervous system, respiratory system, urogenital system, among others. It exports pharmaceuticals and pharmaceutical raw materials in countries including Switzerland, Germany, the Netherlands, the United Kingdom and others.
66GF Score
Get the complete analysis for IST:DEVA
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:DEVA has been successfully added to your 
